U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 260

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr19:18989798
GRCh38:
Chr19:18878989
CERS1, GDF1Progressive myoclonic epilepsy type 8Likely benign
(Jul 19, 2022)
criteria provided, single submitter
2.
GRCh37:
Chr19:19006843
GRCh38:
Chr19:18896034
CERS1, GDF1Progressive myoclonic epilepsy type 8Likely benign
(Apr 1, 2022)
criteria provided, single submitter
3.
GRCh37:
Chr19:19006690
GRCh38:
Chr19:18895881
CERS1, GDF1Progressive myoclonic epilepsy type 8Likely benign
(Oct 31, 2022)
criteria provided, single submitter
4.
GRCh37:
Chr19:18990104
GRCh38:
Chr19:18879295
CERS1, GDF1Progressive myoclonic epilepsy type 8Likely benign
(Aug 23, 2022)
criteria provided, single submitter
5.
GRCh37:
Chr19:19006626
GRCh38:
Chr19:18895817
CERS1, GDF1Progressive myoclonic epilepsy type 8Likely benign
(Aug 5, 2022)
criteria provided, single submitter
6.
GRCh37:
Chr19:18990043
GRCh38:
Chr19:18879234
GDF1, CERS1Progressive myoclonic epilepsy type 8Likely benign
(Aug 9, 2022)
criteria provided, single submitter
7.
GRCh37:
Chr19:19006687
GRCh38:
Chr19:18895878
CERS1, GDF1Progressive myoclonic epilepsy type 8Likely benign
(Oct 4, 2022)
criteria provided, single submitter
8.
GRCh37:
Chr19:19004388
GRCh38:
Chr19:18893579
GDF1, CERS1Progressive myoclonic epilepsy type 8Likely benign
(Oct 14, 2022)
criteria provided, single submitter
9.
GRCh37:
Chr19:18994968
GRCh38:
Chr19:18884159
GDF1, CERS1R173H, R75HProgressive myoclonic epilepsy type 8Uncertain significance
(May 31, 2022)
criteria provided, single submitter
10.
GRCh37:
Chr19:19006684
GRCh38:
Chr19:18895875
CERS1, GDF1Progressive myoclonic epilepsy type 8Likely benign
(Oct 17, 2022)
criteria provided, single submitter
11.
GRCh37:
Chr19:19006845
GRCh38:
Chr19:18896036
GDF1, CERS1P13TProgressive myoclonic epilepsy type 8Uncertain significance
(Jan 18, 2022)
criteria provided, single submitter
12.
GRCh37:
Chr19:18991168
GRCh38:
Chr19:18880359
GDF1, CERS1I125V, I208V, I223VProgressive myoclonic epilepsy type 8Uncertain significance
(Oct 3, 2022)
criteria provided, single submitter
13.
GRCh37:
Chr19:18994900
GRCh38:
Chr19:18884091
GDF1, CERS1F196I, F98IProgressive myoclonic epilepsy type 8Uncertain significance
(Apr 18, 2022)
criteria provided, single submitter
14.
GRCh37:
Chr19:18981432
GRCh38:
Chr19:18870623
CERS1, GDF1Progressive myoclonic epilepsy type 8Likely benign
(Jul 11, 2022)
criteria provided, single submitter
15.
GRCh37:
Chr19:18989765
GRCh38:
Chr19:18878956
GDF1, CERS1Progressive myoclonic epilepsy type 8Likely benign
(Feb 15, 2022)
criteria provided, single submitter
16.
GRCh37:
Chr19:18990200
GRCh38:
Chr19:18879391
CERS1, GDF1Progressive myoclonic epilepsy type 8Uncertain significance
(Feb 4, 2022)
criteria provided, single submitter
17.
GRCh37:
Chr19:19004404
GRCh38:
Chr19:18893595
GDF1, CERS1Progressive myoclonic epilepsy type 8Likely benign
(Mar 1, 2022)
criteria provided, single submitter
18.
GRCh37:
Chr19:18991201
GRCh38:
Chr19:18880392
CERS1, GDF1S212G, S114GProgressive myoclonic epilepsy type 8Uncertain significance
(Feb 1, 2022)
criteria provided, single submitter
19.
GRCh37:
Chr19:18991252
GRCh38:
Chr19:18880443
CERS1, GDF1Progressive myoclonic epilepsy type 8Likely benign
(Jan 26, 2022)
criteria provided, single submitter
20.
GRCh37:
Chr19:18990039
GRCh38:
Chr19:18879230
GDF1, CERS1Progressive myoclonic epilepsy type 8Likely benign
(Apr 24, 2022)
criteria provided, single submitter
21.
GRCh37:
Chr19:18990110
GRCh38:
Chr19:18879301
CERS1, GDF1Progressive myoclonic epilepsy type 8Likely benign
(Jul 15, 2022)
criteria provided, single submitter
22.
GRCh37:
Chr19:18991254
GRCh38:
Chr19:18880445
CERS1, GDF1Progressive myoclonic epilepsy type 8Likely benign
(Jun 17, 2022)
criteria provided, single submitter
23.
GRCh37:
Chr19:19006769
GRCh38:
Chr19:18895960
CERS1, GDF1T38KProgressive myoclonic epilepsy type 8Uncertain significance
(Jan 21, 2022)
criteria provided, single submitter
24.
GRCh37:
Chr19:19006867
GRCh38:
Chr19:18896058
CERS1, GDF1Progressive myoclonic epilepsy type 8Likely benign
(Jul 6, 2022)
criteria provided, single submitter
25.
GRCh37:
Chr19:18995066
GRCh38:
Chr19:18884257
CERS1, GDF1Progressive myoclonic epilepsy type 8Likely benign
(Sep 25, 2022)
criteria provided, single submitter
26.
GRCh37:
Chr19:19006780
GRCh38:
Chr19:18895971
CERS1, GDF1Progressive myoclonic epilepsy type 8Likely benign
(Aug 3, 2022)
criteria provided, single submitter
27.
GRCh37:
Chr19:18994885
GRCh38:
Chr19:18884076
GDF1, CERS1Progressive myoclonic epilepsy type 8Likely benign
(Jun 7, 2022)
criteria provided, single submitter
28.
GRCh37:
Chr19:18991247
GRCh38:
Chr19:18880438
GDF1, CERS1Progressive myoclonic epilepsy type 8Benign
(Oct 4, 2022)
criteria provided, single submitter
29.
GRCh37:
Chr19:19004327
GRCh38:
Chr19:18893518
CERS1, GDF1A103T, A5TProgressive myoclonic epilepsy type 8Uncertain significance
(May 4, 2022)
criteria provided, single submitter
30.
GRCh37:
Chr19:19006734
GRCh38:
Chr19:18895925
CERS1, GDF1A50SProgressive myoclonic epilepsy type 8Uncertain significance
(Aug 8, 2022)
criteria provided, single submitter
31.
GRCh37:
Chr19:19006648
GRCh38:
Chr19:18895839
CERS1, GDF1Progressive myoclonic epilepsy type 8Likely benign
(May 10, 2022)
criteria provided, single submitter
32.
GRCh37:
Chr19:18990215
GRCh38:
Chr19:18879406
GDF1, CERS1Progressive myoclonic epilepsy type 8Likely benign
(Dec 31, 2021)
criteria provided, single submitter
33.
GRCh37:
Chr19:18990201
GRCh38:
Chr19:18879392
GDF1, CERS1Progressive myoclonic epilepsy type 8Likely benign
(Jul 9, 2022)
criteria provided, single submitter
34.
GRCh37:
Chr19:19006801
GRCh38:
Chr19:18895992
CERS1, GDF1W27CProgressive myoclonic epilepsy type 8Uncertain significance
(Dec 18, 2021)
criteria provided, single submitter
35.
GRCh37:
Chr19:18989771
GRCh38:
Chr19:18878962
CERS1, GDF1Progressive myoclonic epilepsy type 8Likely benign
(Oct 17, 2022)
criteria provided, single submitter
36.
GRCh37:
Chr19:18990145
GRCh38:
Chr19:18879336
GDF1, CERS1H171Y, H254Y, H269YProgressive myoclonic epilepsy type 8Uncertain significance
(Aug 20, 2022)
criteria provided, single submitter
37.
GRCh37:
Chr19:19006734
GRCh38:
Chr19:18895925
CERS1, GDF1A50PProgressive myoclonic epilepsy type 8Uncertain significance
(Jul 19, 2022)
criteria provided, single submitter
38.
GRCh37:
Chr19:19006865
GRCh38:
Chr19:18896056
CERS1, GDF1P6RProgressive myoclonic epilepsy type 8Uncertain significance
(Mar 17, 2022)
criteria provided, single submitter
39.
GRCh37:
Chr19:18994937
GRCh38:
Chr19:18884128
GDF1, CERS1Progressive myoclonic epilepsy type 8Likely benign
(Feb 5, 2022)
criteria provided, single submitter
40.
GRCh37:
Chr19:18995093
GRCh38:
Chr19:18884284
CERS1, GDF1Progressive myoclonic epilepsy type 8Likely benign
(Jun 5, 2022)
criteria provided, single submitter
41.
GRCh37:
Chr19:18994882
GRCh38:
Chr19:18884073
CERS1, GDF1Progressive myoclonic epilepsy type 8Likely benign
(Feb 20, 2022)
criteria provided, single submitter
42.
GRCh37:
Chr19:18981444
GRCh38:
Chr19:18870635
CERS1, GDF1Progressive myoclonic epilepsy type 8Likely benign
(Sep 21, 2021)
criteria provided, single submitter
43.
GRCh37:
Chr19:18991259
GRCh38:
Chr19:18880450
CERS1, GDF1Progressive myoclonic epilepsy type 8Likely benign
(Dec 7, 2020)
criteria provided, single submitter
44.
GRCh37:
Chr19:19006726
GRCh38:
Chr19:18895917
CERS1, GDF1Progressive myoclonic epilepsy type 8Likely benign
(Nov 26, 2020)
criteria provided, single submitter
45.
GRCh37:
Chr19:19006711
GRCh38:
Chr19:18895902
GDF1, CERS1Progressive myoclonic epilepsy type 8Likely benign
(Feb 9, 2022)
criteria provided, single submitter
46.
GRCh37:
Chr19:18994881
GRCh38:
Chr19:18884072
CERS1, GDF1Progressive myoclonic epilepsy type 8Likely benign
(Nov 25, 2021)
criteria provided, single submitter
47.
GRCh37:
Chr19:18981436
GRCh38:
Chr19:18870627
CERS1, GDF1Progressive myoclonic epilepsy type 8Likely benign
(Jul 2, 2021)
criteria provided, single submitter
48.
GRCh37:
Chr19:18991118
GRCh38:
Chr19:18880309
CERS1, GDF1Progressive myoclonic epilepsy type 8Likely benign
(Jul 1, 2021)
criteria provided, single submitter
49.
GRCh37:
Chr19:18989759
GRCh38:
Chr19:18878950
CERS1, GDF1Progressive myoclonic epilepsy type 8Likely benign
(Jan 13, 2022)
criteria provided, single submitter
50.
GRCh37:
Chr19:19006816
GRCh38:
Chr19:18896007
CERS1, GDF1Progressive myoclonic epilepsy type 8Likely benign
(Apr 24, 2021)
criteria provided, single submitter
51.
GRCh37:
Chr19:18990030
GRCh38:
Chr19:18879221
CERS1, GDF1Progressive myoclonic epilepsy type 8Likely benign
(Aug 16, 2022)
criteria provided, single submitter
52.
GRCh37:
Chr19:18994928
GRCh38:
Chr19:18884119
GDF1, CERS1Progressive myoclonic epilepsy type 8Likely benign
(Jun 20, 2022)
criteria provided, single submitter
53.
GRCh37:
Chr19:18990170
GRCh38:
Chr19:18879361
GDF1, CERS1Progressive myoclonic epilepsy type 8Likely benign
(Mar 1, 2021)
criteria provided, single submitter
54.
GRCh37:
Chr19:19004340
GRCh38:
Chr19:18893531
CERS1, GDF1Progressive myoclonic epilepsy type 8Likely benign
(Oct 31, 2022)
criteria provided, single submitter
55.
GRCh37:
Chr19:18990182
GRCh38:
Chr19:18879373
CERS1, GDF1Progressive myoclonic epilepsy type 8Likely benign
(Dec 22, 2020)
criteria provided, single submitter
56.
GRCh37:
Chr19:18991259
GRCh38:
Chr19:18880450
CERS1, GDF1Progressive myoclonic epilepsy type 8Likely benign
(Mar 14, 2021)
criteria provided, single submitter
57.
GRCh37:
Chr19:18989720
GRCh38:
Chr19:18878911
GDF1, CERS1Progressive myoclonic epilepsy type 8Likely benign
(Aug 13, 2022)
criteria provided, single submitter
58.
GRCh37:
Chr19:19006702
GRCh38:
Chr19:18895893
CERS1, GDF1Progressive myoclonic epilepsy type 8Likely benign
(Nov 30, 2020)
criteria provided, single submitter
59.
GRCh37:
Chr19:18995066
GRCh38:
Chr19:18884257
CERS1, GDF1Progressive myoclonic epilepsy type 8Likely benign
(Jan 6, 2022)
criteria provided, single submitter
60.
GRCh37:
Chr19:18991103
GRCh38:
Chr19:18880294
CERS1, GDF1Progressive myoclonic epilepsy type 8Likely benign
(Apr 5, 2021)
criteria provided, single submitter
61.
GRCh37:
Chr19:19006873
GRCh38:
Chr19:18896064
CERS1, GDF1Progressive myoclonic epilepsy type 8Likely benign
(Feb 12, 2021)
criteria provided, single submitter
62.
GRCh37:
Chr19:18989721
GRCh38:
Chr19:18878912
CERS1, GDF1Progressive myoclonic epilepsy type 8Likely benign
(Sep 28, 2022)
criteria provided, single submitter
63.
GRCh37:
Chr19:19004247
GRCh38:
Chr19:18893438
CERS1, GDF1Progressive myoclonic epilepsy type 8Likely benign
(Aug 26, 2021)
criteria provided, single submitter
64.
GRCh37:
Chr19:19004265
GRCh38:
Chr19:18893456
CERS1, GDF1Progressive myoclonic epilepsy type 8Likely benign
(Oct 4, 2021)
criteria provided, single submitter
65.
GRCh37:
Chr19:18989741
GRCh38:
Chr19:18878932
GDF1, CERS1Progressive myoclonic epilepsy type 8Likely benign
(Mar 19, 2022)
criteria provided, single submitter
66.
GRCh37:
Chr19:18980021
GRCh38:
Chr19:18869212
CERS1, GDF1Progressive myoclonic epilepsy type 8Likely benign
(Sep 9, 2021)
criteria provided, single submitter
67.
GRCh37:
Chr19:18989771
GRCh38:
Chr19:18878962
GDF1, CERS1Progressive myoclonic epilepsy type 8Likely benign
(Jan 13, 2022)
criteria provided, single submitter
68.
GRCh37:
Chr19:18989804
GRCh38:
Chr19:18878995
CERS1, GDF1Progressive myoclonic epilepsy type 8Likely benign
(Oct 5, 2022)
criteria provided, single submitter
69.
GRCh37:
Chr19:18990152
GRCh38:
Chr19:18879343
CERS1, GDF1Progressive myoclonic epilepsy type 8Likely benign
(Oct 2, 2022)
criteria provided, single submitter
70.
GRCh37:
Chr19:18990134
GRCh38:
Chr19:18879325
CERS1, GDF1Progressive myoclonic epilepsy type 8Likely benign
(Aug 15, 2022)
criteria provided, single submitter
71.
GRCh37:
Chr19:19004232
GRCh38:
Chr19:18893423
CERS1, GDF1Progressive myoclonic epilepsy type 8Likely benign
(Mar 25, 2021)
criteria provided, single submitter
72.
GRCh37:
Chr19:19004218
GRCh38:
Chr19:18893409
CERS1, GDF1Progressive myoclonic epilepsy type 8Likely benign
(Dec 4, 2020)
criteria provided, single submitter
73.
GRCh37:
Chr19:18989750
GRCh38:
Chr19:18878941
CERS1, GDF1Progressive myoclonic epilepsy type 8Likely benign
(Aug 9, 2022)
criteria provided, single submitter
74.
GRCh37:
Chr19:18990170
GRCh38:
Chr19:18879361
CERS1, GDF1Progressive myoclonic epilepsy type 8Likely benign
(Sep 7, 2022)
criteria provided, single submitter
75.
GRCh37:
Chr19:18990160
GRCh38:
Chr19:18879351
CERS1, GDF1Progressive myoclonic epilepsy type 8Likely benign
(Apr 10, 2021)
criteria provided, single submitter
76.
GRCh37:
Chr19:19006853-19006864
GRCh38:
Chr19:18896044-18896055
CERS1, GDF1Progressive myoclonic epilepsy type 8Uncertain significance
(May 7, 2022)
criteria provided, single submitter
77.
GRCh37:
Chr19:19004327
GRCh38:
Chr19:18893518
CERS1, GDF1A5S, A103SProgressive myoclonic epilepsy type 8Uncertain significance
(Aug 31, 2021)
criteria provided, single submitter
78.
GRCh37:
Chr19:19004371
GRCh38:
Chr19:18893562
CERS1, GDF1R88QProgressive myoclonic epilepsy type 8Uncertain significance
(Sep 1, 2022)
criteria provided, single submitter
79.
GRCh37:
Chr19:19004285
GRCh38:
Chr19:18893476
GDF1, CERS1A19S, A117SInborn genetic diseases, Progressive myoclonic epilepsy type 8Uncertain significance
(Sep 13, 2023)
criteria provided, multiple submitters, no conflicts
80.
GRCh37:
Chr19:19004284
GRCh38:
Chr19:18893475
CERS1, GDF1A117V, A19VProgressive myoclonic epilepsy type 8Uncertain significance
(Aug 27, 2021)
criteria provided, single submitter
81.
GRCh37:
Chr19:19006800
GRCh38:
Chr19:18895991
CERS1, GDF1G28SProgressive myoclonic epilepsy type 8Uncertain significance
(Oct 14, 2022)
criteria provided, single submitter
82.
GRCh37:
Chr19:19006724
GRCh38:
Chr19:18895915
CERS1, GDF1A53VProgressive myoclonic epilepsy type 8Uncertain significance
(Aug 28, 2021)
criteria provided, single submitter
83.
GRCh37:
Chr19:18991198
GRCh38:
Chr19:18880389
CERS1, GDF1D198N, D115N, D213NProgressive myoclonic epilepsy type 8Uncertain significance
(Aug 30, 2021)
criteria provided, single submitter
84.
GRCh37:
Chr19:18989854
GRCh38:
Chr19:18879045
CERS1, GDF1Progressive myoclonic epilepsy type 8Uncertain significance
(May 27, 2022)
criteria provided, single submitter
85.
GRCh37:
Chr19:19006724
GRCh38:
Chr19:18895915
CERS1, GDF1A53GProgressive myoclonic epilepsy type 8Uncertain significance
(Sep 2, 2021)
criteria provided, single submitter
86.
GRCh37:
Chr19:19006671
GRCh38:
Chr19:18895862
CERS1, GDF1T71AProgressive myoclonic epilepsy type 8Uncertain significance
(Sep 1, 2021)
criteria provided, single submitter
87.
GRCh37:
Chr19:18991110
GRCh38:
Chr19:18880301
GDF1, CERS1L144S, L227S, L242SProgressive myoclonic epilepsy type 8Uncertain significance
(Feb 2, 2022)
criteria provided, single submitter
88.
GRCh37:
Chr19:18990133
GRCh38:
Chr19:18879324
GDF1, CERS1R175C, R258C, R273CProgressive myoclonic epilepsy type 8Uncertain significance
(May 10, 2022)
criteria provided, single submitter
89.
GRCh37:
Chr19:19004329
GRCh38:
Chr19:18893520
GDF1, CERS1S4N, S102NProgressive myoclonic epilepsy type 8Uncertain significance
(Sep 12, 2022)
criteria provided, single submitter
90.
GRCh37:
Chr19:18991137
GRCh38:
Chr19:18880328
CERS1, GDF1H135R, H233R, H218RProgressive myoclonic epilepsy type 8Uncertain significance
(Feb 4, 2022)
criteria provided, single submitter
91.
GRCh37:
Chr19:19004372
GRCh38:
Chr19:18893563
CERS1, GDF1R88WProgressive myoclonic epilepsy type 8Uncertain significance
(Aug 9, 2022)
criteria provided, single submitter
92.
GRCh37:
Chr19:18995046
GRCh38:
Chr19:18884237
CERS1, GDF1D147G, D49GProgressive myoclonic epilepsy type 8Uncertain significance
(Aug 20, 2021)
criteria provided, single submitter
93.
GRCh37:
Chr19:18995082
GRCh38:
Chr19:18884273
CERS1, GDF1Progressive myoclonic epilepsy type 8Uncertain significance
(Sep 1, 2021)
criteria provided, single submitter
94.
GRCh37:
Chr19:19006814
GRCh38:
Chr19:18896005
CERS1, GDF1V23AProgressive myoclonic epilepsy type 8Uncertain significance
(Aug 15, 2022)
criteria provided, single submitter
95.
GRCh37:
Chr19:18989740
GRCh38:
Chr19:18878931
CERS1, GDF1E322Q, E239Q, E337QProgressive myoclonic epilepsy type 8Uncertain significance
(Jan 6, 2022)
criteria provided, single submitter
96.
GRCh37:
Chr19:18995095-18995096
GRCh38:
Chr19:18884286-18884287
CERS1, GDF1Progressive myoclonic epilepsy type 8Likely benign
(Mar 21, 2022)
criteria provided, single submitter
97.
GRCh37:
Chr19:18990115
GRCh38:
Chr19:18879306
CERS1, GDF1P181T, P279T, P264TProgressive myoclonic epilepsy type 8Uncertain significance
(Aug 9, 2022)
criteria provided, single submitter
98.
GRCh37:
Chr19:18893725-19312528
Progressive myoclonic epilepsy type 8Uncertain significance
(Mar 31, 2021)
criteria provided, single submitter
99.
GRCh37:
Chr19:18989775
GRCh38:
Chr19:18878966
CERS1, GDF1T227I, T325I, T310IProgressive myoclonic epilepsy type 8Uncertain significance
(Aug 23, 2021)
criteria provided, single submitter
100.
GRCh37:
Chr19:19004315
GRCh38:
Chr19:18893506
CERS1, GDF1L107V, L9VProgressive myoclonic epilepsy type 8Uncertain significance
(Jun 17, 2022)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination